Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment.
about
Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer.Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression.Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics.
P2860
Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pathology-Driven Comprehensive ...... Cancer Tumor Microenvironment.
@ast
Pathology-Driven Comprehensive ...... Cancer Tumor Microenvironment.
@en
type
label
Pathology-Driven Comprehensive ...... Cancer Tumor Microenvironment.
@ast
Pathology-Driven Comprehensive ...... Cancer Tumor Microenvironment.
@en
prefLabel
Pathology-Driven Comprehensive ...... Cancer Tumor Microenvironment.
@ast
Pathology-Driven Comprehensive ...... Cancer Tumor Microenvironment.
@en
P2093
P50
P1476
Pathology-Driven Comprehensive ...... Cancer Tumor Microenvironment.
@en
P2093
Aurelie Fabre
Claire Tonry
John O'Leary
Lance Liotta
Lisa Staunton
Michaela Bowden
Rosanna Inzitari
Rosina Lis
Virginia Espina
P304
P356
10.1158/1541-7786.MCR-16-0358
P577
2017-01-05T00:00:00Z